Search
for

    Sort by

    Research 991–1000 of 1000+

    1. The Predictive Value of Midscalp Hair Density and Terminal Hair Percentage in the Severity Evaluation of FPHL Assessed by Trichoscan in a Sample of Chinese Population Clinical, Cosmetic and Investigational Dermatology · 2022 · 1 citations
    2. Treatment with oral vitamin D alone, topical minoxidil, or combination of both in patients with female pattern hair loss: A comparative clinical and dermoscopic study Journal of Cosmetic Dermatology · 2022 · 1 citations
    3. The Effectiveness and Tolerability of Preformed Growth Factors Vehiculated Through Iontophoresis on Patients with Androgenetic Alopecia and Telogen Effluvium: A Clinical Study Dermatology practical & conceptual · 2021 · 1 citations
    4. Low-level Laser Therapy with Novel Array of Light Source and Individualized Program for Treatment of Androgenetic Alopecia: A 16-week, Randomized, Double-blind, Sham Device-controlled Study Medical lasers · 2020 · 1 citations
    5. Quality of life and economic burden assessment in Korean patients with male and female pattern hair loss Journal of Clinical Dermatology · 2015 · 1 citations
    6. Einfluss von HRT auf Haut und Haare Gynäkologische Endokrinologie · 2009 · 1 citations
    7. Experience of using a multi-component serum for hair loss in androgenetic alopecia in women Vestnik dermatologii i venerologii · 2026
    8. Needle-free jet delivery of minoxidil in early female pattern hair loss: an observational comparative study in Asian women European Journal of Plastic Surgery · 2026
    9. A 2% Oleosome-FGF-2 Fusion Extract Scalp Serum Improves Photo-trichogramDerived Hair Density, Anagen/Telogen Ratio, Hair Shaft Thickness, and Scalp Barrier Parameters in Women with Shedding-Prone Hair: A Randomized, SingleBlind, Placebo-Controlled Pilot Study International Journal of Clinical & Experimental Dermatology · 2026
    10. Cutaneous Manifestations and Their Relationship with Serum Testosterone and DHEAS Levels in Women with Polycystic Ovary Syndrome: A Cross‑Sectional Clinical Study Zenodo (CERN European Organization for Nuclear Research) · 2026